Amyloidosis

general

A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.

32

Centers

3

Active Trials

$4M

Cancer Funding

Top Centers for Amyloidosis(32)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
70.3
2
NCI Comprehensive
High-Volume Research Center
70.3
3
High-Volume Research Center
70.3
466.4
5
NCI Comprehensive
Active Research Program
65.3
6
NCI Comprehensive
Active Research Program
64.2
7
NCI Comprehensive
47.8
8
NCI Comprehensive
47.8
9
NCI Comprehensive
47.8
10
NCI Comprehensive
47.8
1147.8
1247.8
13
NCI Comprehensive
47.8
14
NCI Comprehensive
47.8
1547.8
16
NCI Clinical
47.8
1747.8
1847.8
19
NCI Comprehensive
47.8
2047.8
2147.8
2247.8
2347.8
24
NCI Comprehensive
47.8
2547.8
2647.8
2747.8
2847.8
2947.8
3047.8
3147.8
3247.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →